Abstract:Background: Patients with nonvalvular atrial fibrillation (NVAF) undergoing left atrial appendage occlusion (LAAO) are at high risk of stroke or bleeding. However, risk factors for their adverse cardiovascular events remain largely unknown. Pulmonary hypertension has been shown to be related to poor prognosis in many heart diseases. In this study, we determined whether elevated pulmonary artery systolic pressure (PASP) is associated with postprocedure adverse events and major adverse cardiovascular events (MACE) in these patients. Methods: From June 2017 and December 2019, 530 consecutive patients with NAVF at high risk of stroke or bleeding who undergone LAAO were retrospectively enrolled in our study. The preprocecure PASP was obtained by transthoracic echocardiography using the simplified Bernoulli’s equation. Patients were followed-up through clinic visits or over the phone at discharge at 1–3 months, 6 months, and annually thereafter. The median follow-up time was 12 months, and clinical data were analyzed. MACE was defined as myocardial infarction, definite heart failure, stroke, or all-cause death. The outcome of postprocedure pericardial effusion included in-hospital pericardial effusion and pericardial effusion detected after discharge. Results: Univariate analyses indicated that patients who had MACE tended to have elevated PASP (P=0.005). After dividing the cohort according to the cut-off value of PASP, Kaplan-Meier curves indicated that patients with PASP ≥39.5 mmHg had a higher risk of MACE (P=0.007) and heart failure hospitalization (P=0.005) compared to patients whose PASP <39.5 mmHg. Cox regression analysis showed that PASP was a predominant risk factor of MACE (HR =2.337, 95% CI, 1.207–4.526, P=0.012) and heart failure hospitalization (HR =3.701, 95% CI, 1.118–12.251, P=0.032). Furthermore, the PASP cut-off added incremental discriminatory capacity to the MACE risk model of this cohort. In addition, logistic regression showed that PASP had as a significant association with postprocedure pericardial effusion (OR =1.061, P=0.032). Conclusions: Elevated PASP was associated with postprocedure pericardial effusion and mid-term MACEs in patients with atrial fibrillation (AF) undergoing LAAO.

Prognostic Effects of Pulmonary Hypertension in Patients Undergoing Cardiac Resynchronization Therapy.

Associations between pulmonary artery systolic pressure and clinical outcome of cardiac resynchronization therapy

Elevated Pulmonary Artery Pressure Predicts Poor Outcome after Cardiac Resynchronization Therapy

Value of pulmonary arterial hypertension in predicting survival after cardiac resynchronization therapy

Association of Pulmonary Artery Pressure Change with Post-Lung Transplantation Survival: Retrospective Analysis of China Registry

Clinical Effect of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure

[Factors Associated with the Efficacy of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure].

Impact of Pulmonary Arterial Systolic Pressure on Patients with Mitral Valve Disease Combined with Atrial Fibrillation.

Mildly Elevated Pulmonary Artery Systolic Pressure is Associated with Extracorporeal Membrane Oxygenation Support after Heart Transplantation

Pulmonary Artery Pressure is Associated with Mid-Term Major Adverse Cardiovascular Events and Postprocedure Pericardial Effusion in Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion.

Correlation of Pulmonary Artery Systolic Pressure With Left Ventricular Ejection Fraction and Other Cardiac Function Parameters

Predictors for Cardiac Resynchronization Therapy Response

IMPLICATION OF PULMONARY ARTERY SYSTOLIC PRESSURE FOR PROLONGED CARDIOPULMONARY BYPASS DURATION IN PATIENTS UNDERGOING RE-REPAIR FOR DEGENERATIVE MITRAL REGURGITATION

Mortality and cause in congestive heart failure patients with cardiac resynchronization therapy

Prognostic Value of Preoperative High-Sensitivity C-reactive Protein to Albumin Ratio in Patients with Dilated Cardiomyopathy Receiving Pacemaker Therapy: A Retrospective Two-Center Study in China

Prognostic Value of Pulmonary Artery Systolic Pressure in Severe Rheumatic Mitral Stenosis

Prognostic Value of Cardiac Magnetic Resonance-Derived Right Ventricular Remodeling Parameters in Pulmonary Hypertension: A Systematic Review and Meta-Analysis.

Elevated Pulmonary Artery Systolic Pressure is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer

Can the Prognosis of Cardiac Resynchronization Therapy Be Predicted by Gated SPECT?

Echocardiographic Estimated Pulmonary Systolic Pressure and Outcome After Noncardiac-Obstetrics Surgery in Postcapillary Pulmonary Hypertensive Patients

Prognostic value of renal function in patients with cardiac resynchronization therapy